A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants. / Drost, Mark; Zonneveld, José B M; van Hees, Sandrine; Rasmussen, Lene Juel; Hofstra, Robert M W; de Wind, Niels.
In: Human Mutation, Vol. 33, No. 3, 2012, p. 488-94.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants
AU - Drost, Mark
AU - Zonneveld, José B M
AU - van Hees, Sandrine
AU - Rasmussen, Lene Juel
AU - Hofstra, Robert M W
AU - de Wind, Niels
N1 - © 2011 Wiley Periodicals, Inc.
PY - 2012
Y1 - 2012
N2 - Lynch syndrome (LS) is an autosomal dominant disorder that predisposes to colon, endometrial, and other cancers. LS is caused by a heterozygous germline mutation in one of the DNA mismatch repair (MMR) genes. A significant proportion of all mutations found in suspected LS patients comprises single amino acid alterations. The pathogenicity of these variants of uncertain significance (VUS) is difficult to assess, precluding diagnosis of carriers and their relatives. Here we present a rapid cell-free assay to investigate MMR activity of MSH2 or MSH6 VUS. We used this assay to analyze a series of MSH2 and MSH6 VUS, selected from the Leiden Open Variation Database. Whereas a significant fraction of the MSH2 VUS has lost MMR activity, suggesting pathogenicity, the large majority of the MSH6 VUS appears MMR proficient. We anticipate that this assay will be an important tool in the development of a comprehensive and widely applicable diagnostic procedure for LS-associated VUS.
AB - Lynch syndrome (LS) is an autosomal dominant disorder that predisposes to colon, endometrial, and other cancers. LS is caused by a heterozygous germline mutation in one of the DNA mismatch repair (MMR) genes. A significant proportion of all mutations found in suspected LS patients comprises single amino acid alterations. The pathogenicity of these variants of uncertain significance (VUS) is difficult to assess, precluding diagnosis of carriers and their relatives. Here we present a rapid cell-free assay to investigate MMR activity of MSH2 or MSH6 VUS. We used this assay to analyze a series of MSH2 and MSH6 VUS, selected from the Leiden Open Variation Database. Whereas a significant fraction of the MSH2 VUS has lost MMR activity, suggesting pathogenicity, the large majority of the MSH6 VUS appears MMR proficient. We anticipate that this assay will be an important tool in the development of a comprehensive and widely applicable diagnostic procedure for LS-associated VUS.
KW - Biological Assay
KW - Blotting, Western
KW - Colorectal Neoplasms, Hereditary Nonpolyposis
KW - DNA-Binding Proteins
KW - Humans
KW - MutS Homolog 2 Protein
KW - Mutation, Missense
KW - Polymerase Chain Reaction
U2 - 10.1002/humu.22000
DO - 10.1002/humu.22000
M3 - Journal article
C2 - 22102614
VL - 33
SP - 488
EP - 494
JO - Human Mutation
JF - Human Mutation
SN - 1059-7794
IS - 3
ER -
ID: 38418760